7,7'-(carbonyl-bis(imino-n-methyl-4,2-pyrrolcarbonylimino(n-methyl-4,2-pyrrol)carbonylimino))-bis(1,3-naphthalenedisulfonic acid) has been researched along with Kaposi Sarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbanti-Brodano, G; Bompadre, S; Campioni, D; Caputo, A; Ciomei, M; Corallini, A; Ferrante, L; Leone, L; Montesi, M; Possati, L; Rocchetti, R; Sola, F; Talevi, S; Trabanelli, C | 1 |
1 other study(ies) available for 7,7'-(carbonyl-bis(imino-n-methyl-4,2-pyrrolcarbonylimino(n-methyl-4,2-pyrrol)carbonylimino))-bis(1,3-naphthalenedisulfonic acid) and Kaposi Sarcoma
| Article | Year |
|---|---|
Antiangiogenic, antitumoural and antimetastatic effects of two distamycin A derivatives with anti-HIV-1 Tat activity in a Kaposi's sarcoma-like murine model.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Distamycins; Drug Screening Assays, Antitumor; Female; Gene Products, tat; Genes, tat; HIV-1; Male; Mice; Mice, Nude; Mice, Transgenic; Minocycline; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Transplantation; Neovascularization, Pathologic; Sarcoma, Kaposi; tat Gene Products, Human Immunodeficiency Virus; Transfection | 1999 |